Uterine Fibroids Clinical Trials

A listing of Uterine Fibroids medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4468 clinical trials
Featured trial
A Phase 2, Open-Label, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement

This is an open-label, monotherapy study of INCB054828 in subjects with myeloid/lymphoid neoplasms with FGFR1 rearrangement.  Subjects will receive a once daily (QD) dose of INCB054828 at 13.5 mg on a 2-week-on–therapy and 1-week-off–therapy schedule.  With Protocol Amendment 3, the administration schedule will be adjusted, and newly enrolled subjects will …

FGFR1
myeloid neoplasm
lymphoid malignancy
  • 182 views
  • 19 Dec, 2022
  • 35 locations
Featured trial
Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus (CLEan)

Primary Objective:

<ul>
  • Assess the efficacy of SAR443122 in cutaneous lupus erythematosus (CLE)
    • ul>

    Secondary Objectives:

    <ul>
  • Assess the effect of SAR443122 on the

    • 25 views
    • 17 Feb, 2023
    • 5 locations
    Featured trial
    Ulcerative Colitis Research Study

    Local doctors are looking for people with Ulcerative Colitis for clinical research studies of an investigational medication.

    <ul>
  • Must be receiving treatment for Ulcerative Colitis
    • ulcerative colitis
    • 954 views
    • 07 Nov, 2020
    • 1 location
    Featured trial
    Efficacy and Safety of SAR441344 in the Treatment of Systemic Lupus Erythematosus (APATURA)

    treatment of participants aged 18 to 70 years with active Systemic Lupus Erythematosus (SLE). Study details include:

    <ul>
  • Study duration: 36 weeks
  • Treatment duration: 24 weeks
  • arthritis
    lupus
    antinuclear antibody
    rash
    • 11 views
    • 03 Mar, 2023
    • 6 locations
    Featured trial
    SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients (CARMEN-LC03)  

    Primary Objectives:

    <ul>
  • Study is designed with two primary endpoints that will be analyzed on randomized participants at the time of the cut-off date for each given analysis

    • 181 views
    • 17 Feb, 2023
    • 5 locations
    Featured trial
    Clinical Study for Treatment-naïve IOPD Babies to Evaluate Efficacy and Safety of ERT With Avalglucosidase Alfa (Baby-COMET)  

    participants with IOPD.

    Study details include:

    <ul>
  • Study duration: Screening - up to 4 weeks;
  • Primary Analysis Period (PAP) - 52 weeks;
  • Extended Treatment Period (ETP) - 52

    deficiency
    replacement therapy
    • 8 views
    • 17 Mar, 2023
    • 3 locations
    Featured trial
    Dose Ranging Study of Amlitelimab in Adult Participants With Moderate-to-severe Asthma (TIDE-asthma)  

    efficacy, safety, and tolerability of add-on therapy with amlitelimab in adult participants with moderate-to-severe asthma.

    Study details include:

    <ul>
  • The study duration (per participant

    • 25 views
    • 15 Mar, 2023
    • 6 locations
    Featured trial
    A Study to Assess if BIIB122 Tablets Are Safe and Can Slow Worsening of Early-Stage Parkinson's Disease in Participants With Specific LRRK2 Genetic Variants Between the Ages of 30 and 80 Using the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (LIGHTHOUSE)

    > To help answer this question, researchers will use a questionnaire called the Movement Disorder Society-Unified Parkinson's Disease Rating Scale, also known as the MDS-UPDRS.

    <ul>
  • The MDS

    movement disorder
    motor symptoms
    hoehn and yahr scale
    depression
    • 5 views
    • 13 Mar, 2023
    • 3 locations
    Featured trial
    Dupilumab in CRSsNP (Liberty CRSsNP ORION)  

    symptom score (sTSS) compared to placebo

    Secondary Objectives:

    Part A

    <ul>
  • To evaluate the efficacy of dupilumab as assessed by the reduction at Week 52 in sinus opacification on

    rhinorrhea
    sinusitis
    sinus surgery
    acute sinusitis
    obstruction
    • 20 views
    • 03 Mar, 2023
    • 8 locations
    Featured trial
    Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment

    The purpose of this study is to see if stimulation of the brain can improve memory. The investigators will use a device called Transcranial Magnetic Stimulation that can stimulate and activate a specific part of the brain that is important for memory. The study will enroll subjects aged 55-100 with …

    • 1 views
    • 04 Nov, 2022
    • 1 location